Leptin-Replacement Therapy for Lipodystrophy

Oral, Elif Arioglu, Simha, Vinaya, Ruiz, Elaine, Andewelt, Alexa, Premkumar, Ahalya, Snell, Peter, Wagner, Anthony J., DePaoli, Alex M. +4 more·2002·New England Journal of Medicine
DOI 10.1056/nejmoa012437

Cited by (1,000)

Items 301–400 of 1,000

  1. Clinical Classification and Treatment of Congenital and Acquired Lipodystrophy
    Jean Lin Chan, Elif A Oral · 2010 · Endocrine Practice
  2. Functional body composition: insights into the regulation of energy metabolism and some clinical applications
    Manfred James Müller, Anja Bosy‐Westphal, Wiebke Later, Verena K. Haas, Martin Heller · 2009 · European Journal of Clinical Nutrition
  3. Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle
    Yasuhiko Minokoshi, Chitoku Toda, Shiki Okamoto · 2012 · Indian Journal of Endocrinology and Metabolism
  4. Leptin and Soluble Leptin Receptor Levels in Plasma and Risk of Type 2 Diabetes in U.S. Women
    Qi Sun, Rob M. van Dam, James B. Meigs, Oscar H. Franco, Christos Socrates Mantzoros, Frank B. Hu · 2009 · Diabetes
  5. Regulation of T Cell-Mediated Hepatic Inflammation by Adiponectin and Leptin
    Joseph A. Sennello, Raja Fayad, Alison Morris, Robert H. Eckel, Esra Asilmaz, Jason M. Montez, Jeffrey M. Friedman, Charles Anthony Dinarello, Giamila Fantuzzi · 2005 · Endocrinology
  6. Low Serum Leptin Predicts Mortality in Patients with Chronic Kidney Disease Stage 5
    Alexandra Scholze, Dirk Rattensperger, Walter Zidek, Martin Tepel · 2007 · Obesity
  7. Adipose tissue and reproduction in women
    HENRY C. L. BOHLER, SriPrakash L. Mokshagundam, Stephen J. Winters · 2009 · Fertility and Sterility
  8. What are subcutaneous adipocytes really good for…?
    Ralf Paus, Johannes Christian Klein, Paska A. Permana, Maciej Owecki, George N. Chaldakov, Markus Böhm, Gary Hausman, Charles Maurice Lapiere, Pepa K. Atanassova, J Sowiński et al. · 2006 · Experimental Dermatology
  9. Brain Signaling Systems in the Type 2 Diabetes and Metabolic Syndrome: Promising Target to Treat and Prevent These Diseases
    Alexander Olegovich Shpakov, Kira Viktorovna Derkach, Lev M. Berstein · 2015 · Future Science OA
  10. Adipocytokines, cardiovascular pathophysiology and myocardial protection
    Christopher Smith, Derek M. Yellon · 2010 · Pharmacology & Therapeutics
  11. Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy
    Vicente Estrada, María Teresa Martínez-Larrad, José Luis González‐Sánchez, Noemí González Pérez de Villar, Katja K.H. Aben, Cristina Fernández, Manuel Serrano‐Ríos · 2006 · Metabolism
  12. 20 years of leptin: From the discovery of the leptin gene to leptin in our therapeutic armamentarium
    Jeffrey M. Friedman, Christos Socrates Mantzoros · 2014 · Metabolism
  13. Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy
    Jacques Beltrand, Màrta Beregszàszi, Didier Chevenne, Guy H. Sebag, Marc de Kerdanet, Frédéric Huet, Michel Polak, Nadia Tubiana‐Rufi, Didier Lacombe, Alex M. De Paoli et al. · 2007 · PEDIATRICS
  14. Molecular and Cellular Bases of Lipodystrophy Syndromes
    Jamila Zammouri, Camille Vatier, Émilie Capel, Martine Auclair, Caroline Storey, Élise Bismuth, Héléna Mosbah, Bruno Donadille, Sonja Janmaat, Bruno Fève et al. · 2022 · Frontiers in Endocrinology
  15. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats
    Bethany P. Cummings, Ahmed Bettaieb, James Lawrence Graham, Kimber L. Stanhope, Riva Dill, Gregory J. Morton, Fawaz G. Haj, Peter Joseph Havel · 2011 · Proceedings of the National Academy of Sciences
  16. Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome
    Robert Alexander Hegele · 2003 · Trends in Endocrinology and Metabolism
  17. Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management
    Piero Portincasa, Ignazio Grattagliano, Vincenzo Ostilio Palmieri, Giuseppe Palasciano · 2004 · Clinical Biochemistry
  18. Treatment of metabolic syndrome
    Arati Wagh, Neil J. Stone · 2004 · Expert Review of Cardiovascular Therapy
  19. Central Leptin Receptor Action and Resistance in Obesity
    Christian Bjørbæk · 2009 · Journal of Investigative Medicine
  20. Hyperleptinemia: Protecting the Heart From Lipid Overload
    Unger, Roger H. · 2005 · Hypertension
  21. Hepatokines and non-alcoholic fatty liver disease
    Lebensztejn, Dariusz M., Flisiak-Jackiewicz, Marta, Białokoz-Kalinowska, Irena, Bobrus-Chociej, Anna, Kowalska, Irina · 2016 · Acta Biochimica Polonica
  22. Steroid receptor coactivator-1 modulates the function of Pomc neurons and energy homeostasis
    Yongjie Yang, Agatha A. van der Klaauw, Liangru Zhu, Tessa M. Cacciottolo, Yanlin He, Lukas Kurt Josef Stadler, Chunmei Wang, Pingwen Xu, Kenji Saito, Antentor Othrell Hinton Jr. et al. · 2019 · Nature Communications
  23. Neuroendocrine body weight regulation: integration between fat tissue, gastrointestinal tract, and the brain.
    César Luiz Boguszewski, Gilberto Paz-Filho, Licio Augusto Velloso · 2010 · PubMed
  24. Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease?
    Paolo Calabrò, Enrica Golia, Valeria Maddaloni, Marco Malvezzi, Beniamino Casillo, Carla Marotta, Raffaele Calabrò, Paolo Golino · 2008 · Internal and Emergency Medicine
  25. The effects of high fat diets on the blood–brain barrier transport of leptin: Failure or adaptation?
    William A. Banks, Susan A. Farr, John Edward Morley · 2006 · Physiology & Behavior
  26. Intra-abdominal adiposity, inflammation, and cardiovascular risk: New insight into global cardiometabolic risk
    Paolo Calabrò, Edward T.H. Yeh · 2008 · Current Hypertension Reports
  27. Protein Tyrosine Phosphatase 1B
    William S. Cook, Roger H. Unger · 2002 · Developmental Cell
  28. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease
    Tomáš Roubíček, Markéta Bártlová, Jana Krajickova, D Haluzíková, Miloš Mráz, Z Lacinová, Michal Kudla, Vladimı́r Teplan, Martin Haluzı́k · 2009 · Nutrition
  29. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson‐Mendenhall syndrome
    Cochran, Elaine, Young, Janice Ryan, Sebring, Nancy, DePaoli, Alex, Oral, Elif Arioglu, Gorden, Phillip · 2004 · The Journal of Clinical Endocrinology & Metabolism
  30. Control of Energy Homeostasis: Role of Enzymes and Intermediates of Fatty Acid Metabolism in the Central Nervous System
    Michael J. Wolfgang, M. Daniel Lane · 2006 · Annual Review of Nutrition
  31. Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance
    Franck Mauvais‐Jarvis, Rohit Kulkarni, C. Ronald Kahn · 2002 · Clinical Endocrinology
  32. Adipocyte-Derived Hormone Levels in HIV Lipodystrophy
    Lisa A. Kosmiski, Daniel R. Kuritzkes, Kenneth A. Lichtenstein, Robert H. Eckel · 2003 · Antiviral Therapy
  33. Neuroprotective effects of leptin in the context of obesity and metabolic disorders
    Cecilia Davis, Jeremy Mudd, Meredith A. Hawkins · 2014 · Neurobiology of Disease
  34. Adipose tissue dysfunction in obesity and lipodystrophy
    Abhimanyu Garg · 2006 · Clinical cornerstone
  35. Leptin alters energy intake and fat mass but not energy expenditure in lean subjects
    Pavlina Chrysafi, Nikolaos Perakakis, Olivia M. Farr, Konstantinos Stefanakis, Natia Peradze, Aleix Sala‐Vila, Christos Socrates Mantzoros · 2020 · Nature Communications
  36. Soy isoflavones, diet and physical exercise modify serum cytokines in healthy obese postmenopausal women
    Plácido Llaneza, C. González, José Fernández-Iñarrea, Ana Alonso, Fernando Dı́az, Ignacio Arnott, Javier Ferrer-Barriendos · 2010 · Phytomedicine
  37. Serum levels of fibroblast growth factor‐21 are increased in chronic and acute renal dysfunction
    Janka Hindricks, Thomas Ebert, Anette Bachmann, Susan Kralisch, Ulrike Lössner, Jürgen Kratzsch, Jens‐Uwe Stolzenburg, Anja Dietel, Joachim Beige, Matthias Stephan Anders et al. · 2013 · Clinical Endocrinology
  38. Type 1 Diabetes Associated with Acquired Generalized Lipodystrophy and Insulin Resistance: The Effect of Long-Term Leptin Therapy
    Jean Y. Park, Angeline Y. Chong, Elaine K. Cochran, David Erwin Kleiner, Michael J. Haller, Desmond Schatz, Phillip Görden · 2007 · The Journal of Clinical Endocrinology & Metabolism
  39. Leptin deficiency andleptingene mutations in obese children from Pakistan
    Warda Fatima, Adeela Shahid, Muhammad Imran, Jaida Manzoor, Shahida Hasnain, Sobia Rana, Saqib Mahmood · 2011 · International Journal of Pediatric Obesity
  40. Pancreatic Fat Accumulation, Fibrosis, and Acinar Cell Injury in the Zucker Diabetic Fatty Rat Fed a Chronic High-Fat Diet
    Akiko Matsuda, Naohiko Makino, Tomohiro Tozawa, Nakao Shirahata, Teiichiro Honda, Yushi Ikeda, Hideyuki Sato, Miho Ito, Yasuharu Kakizaki, Manabu Akamatsu et al. · 2014 · Pancreas
  41. Adipokines and Aging
    Yasumichi Arai, Michiyo Takayama, Yukiko Abe, Nobuyoshi Hirose · 2011 · Journal of Atherosclerosis and Thrombosis
  42. Diseases of adipose tissue: genetic and acquired lipodystrophies
    Jacqueline Capeau, Jocelyne Magré, Olivier Lascols, Martine Caron, Véronique Béréziat, Corinne Vigouroux, Jean‐Philippe Bastard · 2005 · Biochemical Society Transactions
  43. Rationale for Leptin-Replacement Therapy for Severe Lipodystrophy
    Elif A Oral, Jean Lin Chan · 2010 · Endocrine Practice
  44. PASylation of Murine Leptin Leads to Extended Plasma Half-Life and Enhanced in Vivo Efficacy
    Volker Morath, Florian Bolze, Martin Schlapschy, Sarah E. Schneider, Ferdinand Sedlmayer, Katrin Seyfarth, Martin Klingenspor, Arne Skerra · 2015 · Molecular Pharmaceutics
  45. Leptin, An Adipokine With Central Importance in the Global Obesity Problem
    Jeffrey Ian Mechanick, Shan Zhao, William Timothy Garvey · 2017 · Global Heart
  46. The genetics of lipid storage and human lipodystrophies
    Ann L. Robbins, David B. Savage · 2015 · Trends in Molecular Medicine
  47. Leptin controls the fate of fatty acids in isolated rat white adipocytes
    William WN, Rolando Bacis Ceddia, Rui Curi · 2002 · Journal of Endocrinology
  48. The pharmacological potential and possible molecular mechanisms of action of Inonotus obliquus from preclinical studies
    Kingsley C. Duru, Elena G. Kovaleva, Irina Georgievna Danilova, Pieter van der Bijl · 2019 · Phytotherapy Research
  49. Correlation of Adiponectin and Leptin with Insulin Resistance: A Pilot Study in Healthy North Indian Population
    Amita Yadav, Pramila jyoti, S. K. Jain, Jayashree Bhattacharjee · 2011 · Indian Journal of Clinical Biochemistry
  50. Adiposopathy: why do adiposity and obesity cause metabolic disease?
    Harold Edward Bays, Christie Mitchell Ballantyne · 2006 · Future Lipidology
  51. Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle
    Gregory R. Steinberg, Angela C. Smith, Sam Wormald, Patrick Malenfant, Cheryl Collier, David J. Dyck · 2004 · American Journal of Physiology-Endocrinology and Metabolism
  52. Understanding wound healing in obesity
    Asha C. Cotterell, Michelle Griffin, Mauricio A. Downer, Jennifer B. Laufey Parker, Derrick C. Wan, Michael Thornton Longaker · 2024 · World Journal of Experimental Medicine
  53. Disruption of Hepatic Leptin Signaling Protects Mice From Age- and Diet-Related Glucose Intolerance
    Frank K. Huynh, Jasna Levi, Heather C. Denroche, Sarah Louise Gray, Peter J. Voshol, Ursula H. Neumann, Madeleine Speck, Streamson C. Chua, Scott D. Covey, Timothy J. Kieffer · 2010 · Diabetes
  54. Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy
    Cristina Adelia Meehan, Elaine K. Cochran, Andrea Kassai, Rebecca J. Brown, Phillip Görden · 2015 · Expert Review of Clinical Pharmacology
  55. Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
    Chan, Jean L., Koda, Joy, Heilig, Joseph S., Cochran, Elaine K., Gorden, Phillip, Oral, Elif A., Brown, Rebecca J. · 2016 · Clinical Endocrinology
  56. Leptin Activates Hepatic 5′-AMP-activated Protein Kinase through Sympathetic Nervous System and α1-Adrenergic Receptor
    Licht Miyamoto, Ken Ebihara, Toru Kusakabe, Daisuke Aotani, Sachiko Yamamoto‐Kataoka, Takeru Sakai, Megumi Aizawa‐Abe, Yuji Yamamoto, Junji Fujikura, Tatsuya Hayashi et al. · 2012 · Journal of Biological Chemistry
  57. HIV‐associated Lipodystrophy Syndrome: A Review of Clinical Aspects
    Jean-Guy Baril, Patrice Junod, Roger P. LeBlanc, Harold Dion, Rachel Therrien, François Laplante, Julian Falutz, Pierre Cote, Marie-Nicole Hébert, RICHARD G. LALONDE et al. · 2005 · Canadian Journal of Infectious Diseases and Medical Microbiology
  58. Management of the metabolic effects of HIV and HIV drugs
    Todd Tarquin Brown, Marshall Jay Glesby · 2011 · Nature Reviews Endocrinology
  59. Starvation in the Midst of Plenty: Reflections on the History and Biology of Insulin and Leptin
    Jeffrey S. Flier · 2018 · Endocrine Reviews
  60. New Pharmacological Perspectives for the Leptin Receptor in the Treatment of Obesity
    Clara Roujeau, Ralf Jockers, Julie Dam · 2014 · Frontiers in Endocrinology
  61. Thiazolidinediones ? some recent developments
    Michael Stümvoll · 2003 · Expert Opinion on Investigational Drugs
  62. Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of ‘systemic steatosis’
    Ashok Balasubramanyam, Rajagopal V. Sekhar, Farook Jahoor, Peter H. Jones, Henry J. Pownall · 2004 · Current Opinion in Lipidology
  63. The influence of very-low-calorie diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women
    Kateřina Anderlová, J Křemen, R Doležalová, Jitka Housova, D Haluzíková, Marie Kunešová, Martin Haluzı́k · 2006 · Physiological Research
  64. Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene
    Katharine R. Owen, Mollie E. Donohoe, Sian Ellard, Andrew Tym Hattersley · 2003 · Diabetic Medicine
  65. Structure of the Human Obesity Receptor Leptin-Binding Domain Reveals the Mechanism of Leptin Antagonism by a Monoclonal Antibody
    Byron Carpenter, Glyn R. Hemsworth, Zida Wu, Mabrouka Maamra, Christian Joseph Strasburger, Richard John M Ross, Peter J. Artymiuk · 2012 · Structure
  66. Leptin as a Modulator of Neuroendocrine Function in Humans
    Sami M. Khan, Ole‐Petter R. Hamnvik, Mary T. Brinkoetter, Christos Socrates Mantzoros · 2012 · Yonsei Medical Journal
  67. Development of insulin resistance and hyperphagia in Zucker fatty rats
    Holiday A. Durham, Gary E. Truett · 2005 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  68. Inherited lipodystrophies and hypertriglyceridemia.
    Simha, Vinaya, Garg, Abhimanyu · 2009 · Current Opinion in Lipidology
  69. Metabolism and autophagy in the immune system: immunometabolism comes of age
    Jeffrey C. Rathmell · 2012 · Immunological Reviews
  70. Leptin Replacement Therapy Modulates Circulating Lymphocyte Subsets and Cytokine Responsiveness in Severe Lipodystrophy
    Elif A Oral, Edward D. Javor, Li Ding, Gülbû Uzel, Elaine K. Cochran, Janice Ryan Young, Alex M. DePaoli, Steven M. Holland, Phillip Görden · 2006 · The Journal of Clinical Endocrinology & Metabolism
  71. Adipose Endocrine Function, Insulin-Like Growth Factor-1 Axis, and Exceptional Survival Beyond 100 Years of Age
    Y. Arai, Mina Takayama, Yasuyuki Gondo, Hiroki Inagaki, Ken Yamamura, S. Nakazawa, Taro Kojima, Yoshinori Ebihara, Kohichi Shimizu, Yukie Masui et al. · 2008 · The Journals of Gerontology Series A
  72. Leptin as a neuroprotective agent
    Bor Luen Tang · 2008 · Biochemical and Biophysical Research Communications
  73. Insulin Resistance: A Proinflammatory State Mediated by Lipid‐Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
    Fabrizio Montecucco, Sabine Steffens, François Mach · 2008 · Mediators of Inflammation
  74. Leptin and energy expenditure
    Chris J. Hukshorn, Wim H. M. Saris · 2004 · Current Opinion in Clinical Nutrition & Metabolic Care
  75. Adipose tissue transplantation protects ob/ob mice from obesity, normalizes insulin sensitivity and restores fertility
    Simon Klebanov, Clinton M. Astle, Olga DeSimone, Vitaly G. Ablamunits, David E. Harrison · 2005 · Journal of Endocrinology
  76. Rethinking the central causes of diabetes
    Joel Keith Elmquist, Jacob Marcus · 2003 · Nature Medicine
  77. Effects of Metreleptin in Pediatric Patients With Lipodystrophy
    Brown, Rebecca J., Meehan, Cristina Adelia, Cochran, Elaine, Rother, Kristina I., Kleiner, David E., Walter, Mary, Gorden, Phillip · 2017 · The Journal of Clinical Endocrinology & Metabolism
  78. Type 2 diabetes and cardiovascular disease: getting to the fat of the matterThis paper is one of a selection of papers published in this Special Issue, entitled Young Investigators' Forum.
    Kerry B. Goralski, Christopher J. Sinal · 2007 · Canadian Journal of Physiology and Pharmacology
  79. Adipokines in the treatment of diabetes mellitus and obesity
    Victoria Catalán, Javier Gómez‐Ambrosi, Amaia Rodrı́guez, Javier Salvador, Gema Frühbeck · 2009 · Expert Opinion on Pharmacotherapy
  80. Alterações metabólicas da síndrome lipodistrófica do HIV
    Angelica Valente, André Fernandes Reis, Daisy Maria Machado, Regina Célia de Menezes Succi, Antônio Roberto Chacra · 2005 · Arquivos Brasileiros de Endocrinologia & Metabologia
  81. Non-alcoholic Steatohepatitis in Children
    Eve A. Roberts · 2007 · Clinics in Liver Disease
  82. Adipokines from white adipose tissue in regulation of whole body energy homeostasis
    Bijayashree Sahu, Naresh Chandra Bal · 2022 · Biochimie
  83. Leptin Increases Hepatic Triglyceride Export via a Vagal Mechanism in Humans
    Matthäus Metz, Marianna Beghini, Peter S. Wolf, Lorenz Pfleger, Martina Theresa Hackl, Magdalena Bastian, Angelika Freudenthaler, Jürgen Harreiter, Maximilian Zeyda, Sabina M. Baumgartner-Parzer et al. · 2022 · Cell Metabolism
  84. Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice
    Hiroyuki Tsuchiya, Yoshito Ikeda, Yu Ebata, Chihiro Kojima, Rikutaro Katsuma, Tatsuaki Tsuruyama, Tomohiko Sakabe, Kohei Shomori, Noriko Komeda, Shoko Oshiro et al. · 2012 · Hepatology
  85. Extracellular Signal–Regulated Kinase in the Ventromedial Hypothalamus Mediates Leptin-Induced Glucose Uptake in Red-Type Skeletal Muscle
    Chitoku Toda, Tetsuya Shiuchi, Haruaki Kageyama, Shiki Okamoto, Eulalia A. Coutinho, Tatsuya Sato, Yuko Okamatsu‐Ogura, Shigefumi Yokota, Kazuyo Takagi, Lijun Tang et al. · 2013 · Diabetes
  86. Central melanocortin signaling restores skeletal muscle AMP-activated protein kinase phosphorylation in mice fed a high-fat diet
    Tanaka, Tomohiro, Masuzaki, Hiroaki, Yasue, Shintaro, Ebihara, Ken, Shiuchi, Tetsuya, Ishii, Takako, Arai, Naoki, Hirata, Masakazu, Yamamoto, Hiroshi, Hayashi, Tatsuya et al. · 2007 · Cell Metabolism
  87. Leptin in Health and Disease: Facts and Expectations at its Twentieth Anniversary
    Stergios A. Pοlyzos, Christos Socrates Mantzoros · 2014 · Metabolism
  88. Adipose tissue as source and target for novel therapies
    Johannes Christian Klein, Nina Perwitz, Daniel Kraus, Mathias Faßhauer · 2005 · Trends in Endocrinology and Metabolism
  89. Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess.
    Chan, Jean L., Bullen, John, Stoyneva, Violeta, DePaoli, Alex M., Addy, Carol, Mantzoros, Christos S. · 2005 · The Journal of Clinical Endocrinology & Metabolism
  90. Hypothalamic Agouti-Related Peptide Neurons and the Central Melanocortin System Are Crucial Mediators of Leptin’s Antidiabetic Actions
    Gabriel Henrique Marques Gonçalves, Wenjing Li, Adriana V.C.-G. Garcia, Mariana Sarto Figueiredo, Christian Bjørbæk · 2014 · Cell Reports
  91. Food intake regulation by leptin: Mechanisms mediating gluconeogenesis and energy expenditure
    Zulfia Hussain, Junaid Ali Khan · 2017 · Asian Pacific Journal of Tropical Medicine
  92. Metabolic syndrome: Evaluation of pathological and therapeutic outcomes
    Phillippa J. Miranda, Ralph A. DeFronzo, Robert M. Califf, John R. Guyton · 2005 · American Heart Journal
  93. Leptin-Replacement Therapy in Lipodystrophy
    Joseph I. Wolfsdorf, Ab Sadeghi‐Nejad, Boris Senior · 2002 · New England Journal of Medicine
  94. Adipose crosstalk with other cell types in health and disease
    Chan Hee J. Choi, Paul Cohen · 2017 · Experimental Cell Research
  95. Leptin in congenital and HIV-associated lipodystrophy
    Michael A. Tsoukas, Olivia M. Farr, Christos Socrates Mantzoros · 2014 · Metabolism
  96. Incendiary Leptin
    Patricia Seoane‐Collazo, Noelia Martínez‐Sánchez, Edward Milbank, Cristina Contreras · 2020 · Nutrients
  97. Rethinking leptin and insulin action: Therapeutic opportunities for diabetes
    Bülent Okan Yıldız, İbrahim C. Haznedaroğlu · 2005 · The International Journal of Biochemistry & Cell Biology
  98. Skeletal Muscle AMP-Activated Protein Kinase Phosphorylation Parallels Metabolic Phenotype in Leptin Transgenic Mice Under Dietary Modification
    Tomohiro Tanaka, Shuji Hidaka, Hiroaki Masuzaki, Shintaro Yasue, Yasuhiko Minokoshi, Ken Ebihara, Hideki Chusho, Yoshihiro Ogawa, Tarō Toyoda, Kenji Sato et al. · 2005 · Diabetes
  99. Leptin Deficiency Contributes to the Pathogenesis of Alcoholic Fatty Liver Disease in Mice
    Xiaobing Tan, Xiuhua Sun, Qiong Li, Yantao Zhao, Wei Hong Zhong, Xinguo Sun, Wei Ping Jia, Craig James McClain, Zhanxiang Zhou · 2012 · American Journal Of Pathology
  100. Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2 lipodystrophic mice independent of hepatocyte leptin receptors
    Vı́ctor Cortés, Kelly M. Cautivo, Shunxing Rong, Abhimanyu Garg, Jay D. Horton, Anil K. Agarwal · 2013 · Journal of Lipid Research